Methylation Biomarkers in Non-Regressive Cervical Intraepithelial Neoplasia Grade 2 Lesions: An

Clinical Editorial

British Journal of Cancer, Published online: 11 April 2026; doi:10.1038/s41416-026-03391-4 Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

PLOS ONERelated by Specialty

Oral cancer awareness in North-Western Italy: community pharmacy survey of adults

Oncology • 24 Jul 2026

BMJ OpenRelated by Specialty

cfDNA blood test versus usual care to reduce colorectal cancer screening disparities: randomised t

Oncology • 24 Jul 2026

Front ImmunolRelated by Specialty

CT-derived topological intratumoral heterogeneity predicts major pathological response in resectab

Oncology • 27 Jul 2026

Br J CancerRelated by Specialty

HDAC6 as a biomarker and regulator of dissemination and relapse in B-ALL

Oncology • 26 Jul 2026

bioRxivRelated by Specialty

Ferritin Heavy Chain Deletion Reduces Tumor Growth and Triggers Iron-Dependent Stress in Medullobl

Oncology • 25 Jul 2026